COVID-19, more commonly referred to as Coronavirus, has become an increasing concern, especially in the world of medical devices. We have collated the following information to hopefully answer any questions you may have about the use of Bedfont® products and consumables.
As a global company, we must first and foremost advise that you follow your local guidelines on whether or not you should continue breath testing at this time.
Please be advised that patients with cold/flu-like symptoms can pose a higher risk of cross infection.
The D-piece™ incorporates a one-way valve and an infection control filter, which has been tested vigorously by Public Health England to prove it removes and trap 99% and 97% of airborne bacteria and viruses respectively. Bedfont® recommends the D-piece™ can be used for a continuous 30 days in conjunction with single-patient-use SteriBreath™ mouthpieces.
Both the D-piece™ filter and OneBreath™ mouthpiece have been tested to filter viruses as small as 24 nanometres in diameter and the Covid-19 virus particle has a diameter of approximately 125 nanometres1. Due to the risky nature of testing live respiratory viruses, a non-pathogenic virus model is used (M2-Coliphage). The filters undergo both bacterial filter efficiency (BFE) and viral filtration efficiency (VFE). The virus model is incredibly penetrable, even more so than a majority of human viruses, therefore makes it a very affective model to use for virus filtration efficiency (VFE) testing. The model virus is approximately 24-26 nanometres in size1 in comparison to COVID-19 virus which is approximately 125 nanometres in size2. Therefore, Bedfont® can conclude that bacterial and viral pathogens (including COVID-19) will effectively be removed by both the D-piece™ filter and OneBreath™ mouthpiece filter at an efficiency rate of >99% (bacteria) and >97% (viruses).
Please note the D-piece™, intended for use with Smokerlyzer®️ CO monitors, includes a bacterial and viral infection control filter and is a trademarked consumable manufactured by Bedfont®️. It is not to be confused with other plastic parts provided by other CO monitor manufacturers, which may not include any infection control filters. Any parts claimed to be “D pieces”, which are not provided by Bedfont®️ Scientific Ltd., are not only fraudulent but do not filter out 99% and 97% of airborne bacteria and viruses respectively.
Furthermore, at Bedfont®, we take great pride manufacturing the most innovative and high-quality products. Being a medical manufacturer means there are a lot of classifications and regulations that we must adhere to regarding our products. We are pleased to say our consumables are manufactured in a certified class 100k clean room, which is the 2nd highest classification for particle filtration (ISO Class 8 against ISO14644-1), guaranteeing cleanliness and quality.
We are proud to say the Bedfont® monitors are integrated with SteriTouch® antimicrobial additives, which eradicate the bacteria and viruses that cause contamination and infection. SteriTouch® has released a statement on COVID-19 which reads, ‘Several of the active substances used by SteriTouch® have been successfully tested against other enveloped viruses, such as Influenza, Avian flu and SARS. It would be reasonable to imply that those same active substances would be effective against COVID-19, but at this stage testing against COVID-19 is not available.’3
If you would like to take extra precautions at this time, Bedfont® recommends wearing gloves when handling the monitors and instead opting for the single-use OneBreath™ mouthpiece, which contains a one-way valve and has be proven to remove and trap 99% and 97% of airborne bacteria and viruses respectively. NHS customers should follow procedures given by the NHS followed by the Infection Control and Maintenance Guidelines provided by Bedfont®.
At this time, Bedfont® suggests the following measures to help reduce the risk of cross-infection:
Use of counterfeit or non-Bedfont® approved accessories and consumables may result in loss of performance and/or damage to your device. This risk of incorrect results could adversely affect patient care. We also remind you that counterfeit and/or non-Bedfont® accessories and consumables do not possess the quality and reliability of the original manufacturer products, nor have they undergone the Toxicology tests to ensure they are fit to be used orally, and therefore their safety and infection control efficacy cannot be guaranteed.
The D-piece™ has been tested by Public Health England to prove it removes and trap 99% and 97% of airborne bacteria and viruses respectively, and contains a one-way valve to prevent patient’s inhaling through the mouthpiece. Bedfont® recommends the D-piece™ can be used for a continuous 30 days in conjunction with single-patient-use SteriBreath™ mouthpieces.
If you have any concerns over multiple use of the D-piece™ mouthpiece filter, Bedfont® can also offer the OneBreath™ mouthpiece, which also contains a one-way valve and has been vigorously by Public Health England to prove it removes and trap 99% of airborne bacteria and 97% viruses. The OneBreath™ mouthpiece is single-use for ‘gold standard’ infection control and can be disposed of according to local waste guidelines immediately after testing to further minimise the risk of cross infection.
NHS customers should follow procedures given by the NHS and the rest of the world should please follow their local guidelines, followed by the Infection Control and Maintenance Guidelines provided by Bedfont®.
As standard practice, Bedfont® recommends that the monitors are wiped down with non-alcoholic antibacterial/viral wipes, provided with the monitor, after each breath test.
The World Health Organisation has labelled the latest strain of coronavirus as Covid-19. The virus that causes the disease has been named as SARS-CoV-2. The Azo Universal wipes provided with the Bedfont® monitors have been tested by the supplier and found effective against SARS-CoV-2, as the product shows efficacy against feline coronavirus, a surrogate coronavirus for SARS-CoV-2. A test report can be shown on request.
We have also conducted testing on a 0.5% Sodium Hypochlorite solution, which was found be effective against SARS-CoV-2. Testing found that a solution of this strength had little effect on the readings and we can safely confirm that Sodium Hypochlorite with a solution ≤0.5% can be applied directly to the Smokerlyzer®, NObreath®, ToxCO® and Gastro+™️ monitors for cleaning. Test reports (138.322, 141.127, 120.241 and 120.242) can be shown on request.
Please see the next question about hand sanitiser containing alcohol.
During the current COVID-19 risk, we understand that using only non-alcohol sanitising products may not be feasible at this time. It is for this reason that we have tested the potential impact alcohol hand sanitising gels might have on device results. From the data obtained, it appears that commonly used hand sanitisers contain up to 73.5% alcohol, therefore we have carried out strenuous testing with a number of hand gels up to this alcohol percentage, using the monitors after the hand sanitiser has completely dried.
After using and allowing hand sanitiser to dry, it was shown to have little effects on the results given by the Smokerlyzer®, ToxCO® and NObreath® range of products. Therefore, we can conclude that hand sanitising products with an alcohol content lower than 73.5% can be used when handling the Smokerlyzer®, ToxCO® and NObreath® monitors, once hands have dried.
We must stress that more long term testing is required to determine whether or not commonly used hand sanitisers containing alcohol affect the sensors overtime, therefore it is still recommended that the user should use non-alcohol sanitising products where possible.
Alcohol sanitisers containing more than 73.5% alcohol should be avoided due to the lack of testing with regard to the impact it could have on readings.
A device accuracy test should be performed periodically to ensure the monitor is working as intended. This can be done with a canister of gas, which can be purchased from Bedfont®.
First and foremost we must ask that you follow your local guidelines on continuing Hydrogen and Methane Breath Testing (HMBT) at this time.
The British Society of Gastroenterology have published their guidelines on carry out GI testing during these current conditions, and recommend home kits for HBMT procedures, which allow patients to carry out the test at home instead of the hospital/clinic environment5.
Therefore, when using the GastroCH4ECK® breath bags in home kits for remote HBMT testing, Bedfont® advises the following:
We are working around the clock to provide you with current and correct information. Please check back daily for all updates regarding Coronavirus and the Bedfont® products and consumables.
If you wish to review any of the reports mentioned above, please email email@example.com.
1. Berkeywaterkb.com. 2020. Is The MS2 – Fr Coliphage Still Known To Be A Good Indicator Of Virus Filtration? Do You Have Tests On Any Other Viruses? – Berkey Knowledge Base. [online] Available at: http://berkeywaterkb.com/is-the-ms2-fr-coliphage-still-known-to-be-a-good-indicator-of-virus-filtration-at-least-one-article-suggests-that-it-might-not-be-do-you-have-tests-on-any-other-viruses/#:~:text=The MS-2 virus is 24-26,both referenced on the chart [Accessed 12 June 2020].
2. Avon-protection.com. 2020. [online] Available at: https://www.avon-protection.com/downloads/product_brochures/GR04471-01%20Coronavirus%20-%20WHITE%20PAPER.pdf [Accessed 12 June 2020].
3. SteriTouch. 2020. CORONAVIRUS – THE STERITOUCH STANCE. [online] Available at: https://www.steritouch.com/portfolio-posts/coronavirus-steritouch-stance/ [Accessed 12 June 2020].
4.NHS. 2020. Coronavirus (COVID-19). [online] Available at: https://www.nhs.uk/conditions/coronavirus-covid-19/ [Accessed 12 June 2020].
5. The British Society of Gastroenterology. 2020. AGIP Council Guidance In Relation To GI Physiology Provision During The COVID-19 Pandemic | The British Society Of Gastroenterology. [online] Available at: https://www.bsg.org.uk/covid-19-advice/agip-council-guidance-in-relation-to-gi-physiology-provision-during-the-covid-19-pandemic/ [Accessed 12 June 2020].
6. New England Journal of Medicine. 2020. Aerosol And Surface Stability Of SARS-Cov-2 As Compared With SARS-Cov-1 | NEJM. [online] Available at: https://www.nejm.org/doi/full/10.1056/NEJMc2004973 [Accessed 12 June 2020].